Xenoma, Inc. announced that it has received a round of funding on September 11, 2020. The transaction included participation from Ono Pharmaceutical Co., Ltd. (TSE:4528) and EPS Holdings, Inc. (TSE:4282).
1st Jan change | Capi. | |
---|---|---|
+3.13% | 43.43B | |
+48.83% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |